Preclinical assessment of anti-cancer therapeutic strategies using in vivo videomicroscopy

Cancer and Metastasis Reviews

Volumn 17, Issue 3, 1998, Pages 263-269

  Chambers, Ann F ^a,b   MacDonald, Ian C ^a   Schmidt, Eric E ^a   Morris, Vincent I ^a   Groom, Alan C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Angiogenesis; In vivo videomicroscopy; Metastasis; Preclinical models; Therapeutics

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BATIMASTAT; GREEN FLUORESCENT PROTEIN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; CELL LOSS; CLINICAL TRIAL; DRUG DESIGN; DRUG MECHANISM; DRUG TARGETING; EXTRAVASATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; METASTASIS INHIBITION; MICROSCOPY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; VIDEORECORDING;

ANIMALS; ANTINEOPLASTIC AGENTS; CHICK EMBRYO; DRUG SCREENING ASSAYS, ANTITUMOR; METALLOENDOPEPTIDASES; MICE; MICROSCOPY, VIDEO; MICROSPHERES; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRIAZOLES;

EID: 0004836017     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006136428254     Document Type: Review

References (31)

1. Chambers AF, MacDonald IC, Schmidt EE, Koop S, Morris VL, Khokha R, Groom AC: Steps in tumor metastasis: New concepts from intravital videomicroscopy. Cancer Metas Rev 14: 279-301, 1995
2. MacDonald IC, Schmidt EE, Morris VL, Groom AC, Chambers AF: In vivo videomicroscopy of experimental hematogenous metastasis: Cancer cell arrest, extravasation and migration. In: Soll DR, Wessels D (eds) Motion Analysis of Living Cells. John Wiley and Sons, New York, 1998, pp 263-287
3. Keep S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, Khokha R, Chambers AF, Groom AC: Fate of melanoma cells entering the microcirculation: Over 80% survive and extravasate. Cancer Res 55: 2520-2523, 1995
4. Morris VL, Luzzi KJ, MacDonald IC, Schmidt EE, Chambers AF, Groom AC: Fate of early metastases: Initial formation of B16F1 micrometastases exceeds eventual tumor count by 100-fold. Proc AACR 39:83 (abstract 566), 1998
5. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC: Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation, and limited survival of early micrometastases. Am J Pathol 153: 865-873, 1998
6. Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metas Rev 10: 229-243, 1991
7. Radinsky R: Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metas Rev 14: 323-338, 1995
8. Welch DR: Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 15: 272-306, 1997
9. Fidler IJ: The biology of human cancer metastasis. Acta Oncol 30: 668-675, 1991
10. Liotta LA, Stetler-Stevenson WG: Principles of molecular cell biology of cancer: cancer metastasis. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 4th Ed., Philadelphia, Lippincott, 1993, pp 134-149
11. MacDonald IC, Ragan DM, Schmidt EE, Groom AC: Kinetics of red blood cell passage through interendothelial slits into venous sinuses in rat spleen, analyzed by in vivo microscopy. Microvase Res 33: 118-134, 1987
12. MacPhee PJ, Schmidt EE, Keown PA, Groom AC: Microcirculatory changes in livers of mice infected with murine hepatitis virus. Evidence from microcorrosion casts and measurements of red cell velocity. Microvasc Res 36: 140-149, 1988
13. Chambers AF, Schmidt EE, MacDonald IC, Morris VL, Groom AC: Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos, studied by high-resolution intravital videomicroscopy. J Natl Cancer Inst 84: 797-803, 1992
14. MacDonald IC, Schmidt EE, Morris VL, Chambers AF, Groom AC: Intravital videomicroscopy of the chorioallantoic microcirculation: A model system for studying metastasis. Microvasc Res 44: 185-199, 1992
15. Morris VL, MacDonald IC, Koop S, Schmidt EE, Chambers AF, Groom AC: Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: Videomicroscopic analysis. Clin Exp Metas 11: 377-390, 1993
16. Morris VL, Schmidt EE, Koop S, MacDonald IC, Grattan M, Khokha R, McLane MA, Niewiarowski S, Chambers AF, Groom AC: Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp Cell Res 219; 571-578, 1995
17. Morris VL, Koop S, MacDonald IC, Schmidt EE, Grattan M, Percy D, Chambers AF, Groom AC: Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metas 12: 357-367, 1994
18. Hangan D, Uniyal S, Morris VL, MacDonald IC, von Ballestrem GG, Chau T, Schmidt EE, Chambers AF, Groom AC, Chan BMC: Integrin VLA-2 (α2β1) function in post-extravasation movement of human rhabdomyosarcoma RD cells in the liver. Cancer Res 56: 3142-3149, 1996
19. Koop S, Schmidt EE, MacDonald IC, Morris VL, Khokha R, Grattan M, Leone J, Chambers AF, Groom AC: Independence of metastatic ability and extravasation: Metastatic rastransformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci USA 93:11080-11084, 1996
20. Weiss L: Metastatic inefficiency. Adv Cancer Res 54: 159-211(1990)
21. DeClerck Y, Imren S: Prolease inhibitors: Role and potential therapeutic use in human cancer. Eur J Cancer 30A: 2127-2180, 1994
22. Brown PD: Malrix metalloproteinase inhibitors: A novel class of anticancer agents. Adv Enz Regul 35: 293-301, 1995
23. Chambers AF, Matrisan LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997
24. Khokha R, Zimmer M, Wilson SM, Chambers AF: Up-regulation of TIMP-I expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metas 10: 365-370, 1992
25. Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86; 299-304, 1994
26. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC: Over-expression of metalloprokinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54: 4791-4797, 1994
27. Wiley S, Mac Donald IC, Varghese HJ, Schmidt EE, Morris VL, Groom AC, Chambers AF: The matrix metalloproteinase inhibitor batimastat inhibits ingiogenesis in liver metastases of B16F1 melanoma cells. Clin Exp Metas, in press
28. Wiley JSM: Effects of the Matrix Metalloproteinase Inhibitor Batimastat on Individual Stages of Metastasis. MSc thesis, Univ. Western Ontario, London, Canada, 1997
29. Kohn EC, Sandeen MA, Liotta LA: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 52: 3208-3212, 1992
30. Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA: Angiogenesis; role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 92; 1307-1311, 1995
31. Christian MC, Pluda JM, Ho PTC, Arbuck SG, Murgo AJ, Sausville EA: Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute. Sem Oncol. 24: 219-240, 1997